Targeted combination therapy halts disease, extends life in advanced melanoma patients
Tuesday, September 30, 2014 - 05:31
in Health & Medicine
A world-first study heralds the efficacy of a targeted combination drug therapy after reporting major declines in the risk of disease progression and death in people with metastatic melanoma.
